Publications

Show: AllPeer ReviewedNon Peer Reviewed
16 non peer reviewed publications from 2018

McDonald AG and Davey GP, 'On/Off Switching During The Synthesis Of Complex Sugars', Science Trends, 2018, -
Digital research resource production; Published; Non Peer Reviewed; Author Profile: GDAVEY; DOI; URL

David K Finlay, What fuels Natural Killer cells against Cancer, Trinity Week Symposium , Exam Hall, TCD, 2018
Invited Talk; Published; Non Peer Reviewed; Author Profile: FINLAYD

David K Finlay, What fuels NK cells to destroy tumours?, Trinity Biomedical Frontiers Series, Trinity Biomedical Sciences Institute, 2018
Invited Talk; Published; Non Peer Reviewed; Author Profile: FINLAYD

Magnano, S., O'Sullivan, J. and Zisterer, D.M., Role of Autophagy in Chemoresistance in Oral Squamous Cell Carcinoma, International Association for Dental Research, London, England, 25 July , 2018
Invited Talk; Presented; Non Peer Reviewed; Author Profile: DZISTRER

Creagh, E.M., Contribution of Inflammatory caspases to IBD & CRC, INITIative Network meeting, Dublin, Ireland, 23rd November 2018, 2018
Invited Talk; Presented; Non Peer Reviewed; Author Profile: ECREAGH

Flis, E and Creagh, E.M., Role of TLR2 in Oesophageal Adenocarcinoma Progression, Training in Cancer Mechanisms & Therapeutics Meeting, Queens University, Belfast, 16th April 2018, 2018
Oral Presentation; Presented; Non Peer Reviewed; Author Profile: ECREAGH

David Finlay, What fuels Natural killer cell anti-tumour responses, Centre d'Etude des Pathologies Respiratoires (CEPR) -Institute Seminar, Tours, France, 29th May, 2018, Centre d'Etude des Pathologies Respiratoires (CEPR)
Invited Talk; Presented; Non Peer Reviewed; Author Profile: FINLAYD

David Finlay, cMyc and Srebp drive glucose fueled Natural Killer responses, Translational Immunometabolism', Cell Press Sympsium, Basel, Switzerland, 24th June, 2018
Oral Presentation; Presented; Non Peer Reviewed; Author Profile: FINLAYD

David Finlay, Fueling Robust Anti-Tumor NK Cell Responses , Discovery on Target Conference; NK cell based Cancer Immunotherapies, Boston, 26 September, 2018
Invited Talk; Presented; Non Peer Reviewed; Author Profile: FINLAYD

Coyle R, O'Sullivan M. & Zisterer DM, Inhibitor of Apoptosis Proteins as Targets for the Treatment of Malignant Rhabdoid Tumor, Irish Association Cancer Research, Crowne Plaza Hotel, Santry, Dublin, 22nd February 2018, 2018
Poster; Presented; Non Peer Reviewed; Author Profile: DZISTRER

Coyle R, O'Sullivan M. & Zisterer DM, Inhibitor of Apoptosis Proteins as Targets for the Treatment of Malignant Rhabdoid Tumor, European Association for Cancer Research, Amsterdam Netherlands, 1 to 3 february 2018, 2018
Poster; Presented; Non Peer Reviewed; Author Profile: DZISTRER

Amet R., Previtali V., Browne P.V., Rozas I., McElligott A.M. & Zisterer D.M. , Novel anti-cancer therapeutics for multiple myeloma which target the STAT3 signalling pathway , European Association for Cancer Research, Amsterdam Netherlands, 1 to 3 february 2018, 2018
Poster; Presented; Non Peer Reviewed; Author Profile: DZISTRER

Amet R, Rozas I, McElligott AM, Browne P and Zisterer DM, Novel Anti-Cancer Therapeutics for Multiple Myeloma that target the STAT3 signalling pathway, Irish Association Cancer Research, Crowne Plaza Hotel, Santry, Dublin, 22nd February 2018, 2018
Poster; Presented; Non Peer Reviewed; Author Profile: DZISTRER

David Finlay, Metabolic regulation of Immune responses., Institute Seminar Series, University of Lausanne, 21st November, 2018, Ping-Chih Ho
Invited Talk; Presented; Non Peer Reviewed; Author Profile: FINLAYD

David Finlay, What fuels Natural Killer Cell anti-tumour responses., Institute Seminar Series, University of Dundee, 28th Feburary, 2018
Invited Talk; Accepted; Non Peer Reviewed; Author Profile: FINLAYD

David Finlay, Metabolic regulation of NK cell anti-tumour responses, Natural Killer Cell Symposium 2018 - of the German Society for Immunology , Hamburg, Germany, 10th September, 2018, Keynote Speaker
Invited Talk; Presented; Non Peer Reviewed; Author Profile: FINLAYD